State of Wyoming’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.5K Sell
556
-2,797
-83% -$392K 0.01% 1364
2025
Q4
$412K Sell
3,353
-1,223
-27% -$149K 0.05% 495
2025
Q3
$508K Buy
+4,576
New +$520K 0.06% 309
2025
Q2
Sell
-842
Closed -$94.3K 1948
2025
Q1
$94.3K Sell
842
-5,542
-87% -$572K 0.01% 1237
2024
Q4
$590K Buy
+6,384
New +$575K 0.08% 194
2024
Q3
Sell
-4,260
Closed -$292K 1775
2024
Q2
$292K Buy
4,260
+1,415
+50% +$94.4K 0.05% 329
2024
Q1
$208K Buy
2,845
+2,261
+387% +$174K 0.03% 581
2023
Q4
$47.3K Sell
584
-2,757
-83% -$215K 0.01% 1329
2023
Q3
$250K Sell
3,341
-263
-7% -$20.2K 0.05% 308
2023
Q2
$278K Buy
3,604
+1,126
+45% +$89.8K 0.08% 218
2023
Q1
$206K Buy
2,478
+620
+33% +$51.4K 0.07% 323
2022
Q4
$160K Sell
1,858
-1,627
-47% -$129K 0.05% 490
2022
Q3
$215K Buy
3,485
+3,206
+1,149% +$202K 0.11% 174
2022
Q2
$17K Sell
279
-2,541
-90% -$157K 0.01% 1492
2022
Q1
$168K Buy
+2,820
New +$180K 0.08% 279
2021
Q2
Sell
-1,362
Closed -$88K 1184
2021
Q1
$88K Buy
+1,362
New +$87.8K 0.14% 128

Other funds holding GILD

State of Wyoming's GILD Position: Q1 2026 in Review

State of Wyoming reduced its Gilead Sciences (GILD) stake by 83% in Q1 2026, selling an estimated $392K and leaving 556 shares worth $77.5K. The position accounts for 0.01% of the portfolio, ranked #1364.

State of Wyoming first reported a position in GILD in Q1 2021 and has held it in 16 quarters since. The position peaked at $590K in Q4 2024. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • State of Wyoming held 556 shares of Gilead Sciences worth $77.5K as of Q1 2026.
  • State of Wyoming sold 2,797 Gilead Sciences shares in Q1 2026, an estimated $392K.
  • Gilead Sciences made up 0.01% of State of Wyoming's portfolio in Q1 2026, its #1364 holding.
  • State of Wyoming first reported a position in Gilead Sciences in Q1 2021 and has held it in 16 quarters since.
  • State of Wyoming's Gilead Sciences position peaked at $590K in Q4 2024.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.